Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sibling-oocyte randomized comparison of Cumulase versus Sigma hyaluronidase for oocyte denudation before ICSI
NL-OMON29487Active, not recruiting
- Sponsor
- Universitair Ziekenhuis Brussel secundaire sponsor: Halozyme Therapeutics Inc., San Diego, USA (free product - Cumulase® - supply for the duration of the study)
- Start
- May 2006
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial in infertility comparing Cumulase denudation with Sigma hyaluronidase denudation (2 arms). Primary endpoints: Oocyte intactness after ICSI and Fertilization rate. Started May 2006; status: active, not recruiting.
02
Drugs
recombinant human hyaluronidase PH20hyaluronidase
03
Conditions
infertility
Beyond the preview
Go deeper on NL-OMON29487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29487.